Skip to main content

A Comprehensive Fundamental Analysis of Al Mansour Pharmaceuticals Industries Co. (IMAP)

Image
By


A Comprehensive Fundamental Analysis of Al Mansour Pharmaceuticals Industries Co. (IMAP)

worldreview1989 - Fundamental analysis is a method of evaluating a security by attempting to measure its intrinsic value. Analysts use financial and economic analysis to assess all aspects of the company, including its financial statements, management, and the overall economic and industry climate. For investors considering Al Mansour Pharmaceuticals Industries Co., publicly traded on the Iraq Stock Exchange (ISX) under the ticker IMAP, a detailed fundamental analysis is crucial.

A Comprehensive Fundamental Analysis of Al Mansour Pharmaceuticals Industries Co. (IMAP)
A Comprehensive Fundamental Analysis of Al Mansour Pharmaceuticals Industries Co. (IMAP)


1. Company and Industry Overview (Qualitative Analysis)

Al Mansour Pharmaceuticals Industries Co. is an Iraq-based entity engaged in the manufacturing of medicines, generic drugs, and medical supplies. Founded in 1992, the company plays a role in Iraq's domestic healthcare sector, aiming to provide effective and affordable treatment options to the public.

A. Business Model and Products

The company's core business involves the production and sale of pharmaceutical and medical supplies. By focusing on domestic manufacturing, Al Mansour Pharma positions itself as a competitive provider, often offering products at competitive prices compared to imported alternatives. Key values highlighted by the company include commitment to society, quality production (holding an ISO 9001 certificate), and continuous development. Their product portfolio includes various therapeutic drugs, such as Ventomaxin, Sulfomaxin, and Hustamaxin.

B. Market and Competitive Landscape

The pharmaceutical industry in Iraq is shaped by the country's healthcare needs, government regulations, and competition from both local and international producers. Key factors influencing this market include:

  • Government Policies: Regulations on drug pricing, imports, and local manufacturing incentives significantly impact profitability.

  • Market Need: A growing population and evolving healthcare infrastructure often drive demand for affordable and accessible drugs.

  • Competition: Al Mansour Pharma must compete with other domestic manufacturers and imported pharmaceuticals, which can be perceived as higher quality or offer a broader range. The company attempts to attract foreign expertise to make its products equivalent in effectiveness and quality to imported ones.

C. Management and Corporate Restructuring

The company underwent a significant restructuring in 2022, focusing on enhancing equipment, staff, and expertise. Such corporate actions are generally aimed at improving operational efficiency and long-term competitiveness. Investors should monitor the effects of this restructuring on future financial performance.

Read Also :

 Fundamental Analysis of Transsion Holdings Co., Ltd. (688036.SH)

The Merits and Demerits of Investing in PT Bank MNC Internasional Tbk. (BABP) Shares

Analyzing PT Astra Otoparts Tbk (AUTO): Pros and Cons of Investing

An Investor's Perspective on PT Anabatic Technologies Tbk. (ATIC) Stock: Pros and Cons

Navigating the Mobility and Logistics Ecosystem: The Pros and Cons of Investing in PT Adi Sarana Armada Tbk. (ASSA)

2. Financial Statement Analysis (Quantitative Analysis)

Quantitative analysis involves scrutinizing the company's financial health, primarily through its income statement, balance sheet, and cash flow statement.

A. Profitability and Efficiency

A review of recent financial data (Trailing Twelve Months - TTM or latest available quarter) reveals key metrics:

  • Net Profit Margin (TTM):

  • Gross Margin (TTM):

  • Return on Equity (ROE) (TTM):

  • Return on Investment (ROI) (TTM):

A net profit margin of around suggests the company is effectively translating revenue into profit. However, the relatively low Return on Equity and Return on Investment (both ) suggests that the company is not utilizing shareholder equity and total invested capital as efficiently as a high-growth company might. Investors should compare these figures to industry averages and historical data.

B. Revenue and Earnings Growth

Analyzing the trend in revenue and earnings is critical for assessing future growth potential:

  • Latest Quarter Revenue: IQD 1,613.47 million

  • Previous Quarter Revenue: IQD 1,470.62 million

  • Latest Quarter Net Income: IQD 282.11 million

  • Previous Quarter Net Income: IQD 311.34 million

While the company saw a quarter-over-quarter increase in revenue (from IQD 1,470.62 million to IQD 1,613.47 million), the net income slightly decreased (from IQD 311.34 million to IQD 282.11 million). This could be due to increased operational costs, higher taxes, or non-recurring expenses. Consistent, sustainable revenue growth coupled with stable or growing net income is the optimal scenario.

C. Balance Sheet and Solvency

The balance sheet provides a snapshot of the company's assets, liabilities, and equity:

  • Total Assets (Latest Quarter): IQD 28,424.88 million

  • Total Liabilities (Latest Quarter): IQD 3,974.06 million

  • Debt-to-Equity Ratio:

A Debt-to-Equity ratio is highly significant, indicating that the company carries virtually no long-term debt. This suggests a very conservative and financially stable position, minimizing financial risk for the company, although it might also indicate that the company is not leveraging its capital structure to maximize returns.

3. Valuation Analysis (Key Ratios)

Valuation ratios help determine if the stock price is justified by the company's financial performance.

  • P/E Ratio (TTM):

  • Price/Book (P/B) Ratio: (This zero value may suggest a data discrepancy or a very unique financial structure/reporting for the specific exchange and should be verified.)

  • Earnings Per Share (EPS) (TTM): -

  • Dividend Yield: (Suggesting the company currently does not pay dividends or the yield is negligible.)

A P/E Ratio of is relatively high and typically suggests that the market has high expectations for the company's future earnings growth, or that the stock is currently overvalued compared to companies with lower P/E multiples. Investors should justify this high P/E with strong projected growth or unique competitive advantages.

4. Conclusion and Investment Outlook

The fundamental analysis of Al Mansour Pharma (IMAP) reveals a company with a strong qualitative foundation in the Iraqi pharmaceutical market, evidenced by its commitment to quality (ISO certification) and recent operational restructuring.

Key Strengths:

  • Zero Long-Term Debt ( D/E Ratio): Strong solvency and minimal financial risk.

  • Solid Net Profit Margin (): Good efficiency in converting sales to profit.

  • Revenue Growth: Demonstrated ability to increase top-line sales, even in the short term.

Key Concerns/Considerations:

  • High P/E Ratio (): Requires substantial future growth to justify the current valuation.

  • Low ROE/ROI (): Indicates less-than-optimal efficiency in generating returns from capital.

  • Fluctuating Net Income: Despite revenue growth, a slight dip in net income suggests cost pressures or operational inefficiencies need monitoring.

  • Geopolitical/Market Risk: As an Iraqi-listed company, it is subject to the unique geopolitical and economic risks of the region.

Investment Recommendation: Potential investors should view IMAP as a company with low financial risk due to its zero debt but one that is priced for significant growth (high P/E). A bullish case for IMAP would rest on the successful execution of its 2022 restructuring plan, sustained double-digit revenue and earnings growth, and the expansion of its market share in the local Iraqi pharmaceutical sector. A cautious approach is warranted until the company demonstrates consistent improvement in its efficiency metrics (ROE/ROI) that can validate its current premium valuation.

About the Author


David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.

He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.

Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.

Editorial Principles

- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance

Areas of Expertise

- Personal Finance
- Investing & Stock Market
- Cryptocurrency & Blockchain
- Insurance
- Banking
- Real Estate
- Business & Entrepreneurship
- Digital Marketing
- Financial Technology (FinTech)

About WorldReview1989

WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.

Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.

David Mulyana  writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks.

Investment Disclaimer

This article is for educational and informational purposes only and should not be considered personalized investment, tax or financial advice. Australian stocks can be volatile and involve currency, market, commodity, regulatory and geopolitical risks. Past performance does not guarantee future results. U.S. investors should conduct their own due diligence and consult a qualified financial or tax professional before investing.

Labels:

Comments

Post a Comment

Popular posts from this blog

Fundamental Analysis of Global Mediacom Tbk (BMTR)

By
Fundamental Analysis of Global Mediacom Tbk (BMTR) – Financial Performance & Investment Outlook Fundamental Analysis of Global Mediacom Tbk (BMTR) As the parent company of a sprawling media empire, PT Global Mediacom Tbk (BMTR) is a major player in Indonesia's media and entertainment landscape. A fundamental analysis of this company is more complex than analyzing a single-sector business. It requires a deep understanding of the media industry, the dynamics of its various subsidiaries, and a meticulous review of its consolidated financial statements.  Fundamental Analysis of Global Mediacom Tbk (BMTR) 1. Macro and Industry Context: The Media Landscape in Indonesia The performance of BMTR is heavily influenced by the broader media and advertising market in Indonesia. Advertising Spending: The health of the advertising industry is a key driver of revenue for media companies. An analysis would look at trends in corporate advertising budgets, especiall...
Post a Comment
Read more

Want to sell a house? Use this way to make it expensive

By
   The prolonged Covid-19 pandemic sent many people into a financial crisis. Businesses are deserted, turnover drags, savings are drained, and debts pile up. Inevitably, valuable assets are sold. One of them is  property , such as hotels, villas, apartments,  houses , to rents. All this is done to save  finances , including paying debts to get out of the famine. But take it easy, not everyone has fared that way. There are still people whose finances are adem ayem in the midst of a pandemic. I have a lot of money in savings. They're just holding back on spending. Once the time is right, they will shop or spend again, such as buying a house or property.  Well, after Lebaran can be the right moment to buy and sell a house. For those of you who want to sell a post-Lebaran house, here are tips to sell and the price is expensive: Home renovations Prospective buyers are reluctant to buy a home that has a lot of damage. Before it is sold, you will have to renov...
4 comments
Read more

Fundamental Analysis of Transsion Holdings Co., Ltd.

By
  Fundamental Analysis of Transsion Holdings Co., Ltd. (688036.SH) Transsion Holdings Co., Ltd. (SSE: 688036) is a major player in the global mobile phone industry, uniquely positioned as the "King of Africa" for its dominant market share in the continent. A comprehensive fundamental analysis of the company involves scrutinizing its business model, financial health, growth prospects, and competitive landscape. Fundamental Analysis of Transsion Holdings Co., Ltd. 1. Business Overview and Market Position Transsion Holdings, founded in 2006 in Hong Kong and headquartered in Shenzhen, China, primarily engages in the research and development, production, and sales of mobile intelligent terminal operating systems and mobile devices , along with providing mobile internet services. Core Business Model Transsion's strategy focuses almost exclusively on emerging markets , particularly Africa , as well as South Asia, Southeast Asia, the Middle East, and Latin America. Unlike...
Post a Comment
Read more

Top Undervalued Indonesian Stocks to Buy in 2026 (By Sector & Valuation)

By
Comprehensive Look at Top Financial Trends and Insights (2025) Worldreview1989 -   Finding value in the stock market often means looking for companies that the market has temporarily overlooked despite their strong fundamentals. In the context of the Indonesia Stock Exchange (IDX) in 2025, several "blue-chip" and mid-cap stocks are trading at valuations significantly lower than their historical averages or intrinsic values. Here is a comprehensive look at the top undervalued stocks in Indonesia for 2025, categorized by sector and valuation metrics. Read Also :  Stages of the Steam Power Generation Process Here is a comprehensive look at the top undervalued stocks in Indonesia for 2025, categorized by sector and valuation metrics 1. The Banking Sector: Value in Stability Indonesian banks are known for their high profitability (ROE) and robust dividends. While some have reached all-time highs, a few remain attractively priced relative to their lon...
Post a Comment
Read more

MSCI Inclusion Stocks February 2026: Top Candidates & Investor Outlook

By
Worldreview1989 -   The Morgan Stanley Capital International (MSCI) Index rebalancing is one of the most anticipated events for Indonesian investors. As the February 2026 Quarterly Index Review approaches, market participants are closely watching several high-profile stocks that have the potential to "graduate" into the MSCI Global Standard Index. The official announcement is scheduled for February 10, 2026 , with the changes becoming effective at the market close on February 27, 2026 . Read Also :  Fundamental Analysis of Transsion Holdings Co., Ltd. (688036.SH) List of Stocks Potentially Included in the MSCI Index in February 2026 Why the MSCI Index Rebalancing Matters The MSCI Index serves as a primary benchmark for institutional investors and global fund managers. When a stock is included: Passive Inflow: Exchange-Traded Funds (ETFs) and mutual funds tracking the index are mandated to buy the stock. Enhanced Visibility: It puts the company on the radar of globa...
Post a Comment
Read more

Emergency Fund: Benefits, Ideal Amount, Tips for Accumulating It

By
 No one can be certain what the future will hold. Meanwhile, unexpected events, such as job loss or worsening health conditions, are very likely to occur. But don't be discouraged. Even though you can't predict the future, you can still reduce your risk of loss and maintain financial stability through an emergency fund. Emergency Fund: Benefits, Ideal Amount, Tips for Accumulating It What Is an Emergency Fund? Imagine having a secret savings account you can rely on in times of emergency and unforeseen circumstances. That's what an emergency fund is, folks! An emergency fund is a specific amount of money set aside to deal with unexpected situations that can cause a headache, such as job loss, sudden home repairs, or costly health issues. An emergency fund is your financial safety net to ensure you remain calm when life's storms hit. Benefits of an Emergency Fund Used in times of emergency, there are several benefits you can gain from an emergency fund, including: 1. ...
4 comments
Read more

Top Undervalued Swedish Stocks to Buy in 2026 Value Drivers Explained

By
Comprehensive Analysis of Financial Insights and Market Overview Top Undervalued Swedish Stocks to Buy in 2026: Value Drivers Explained Worldreview1989 - Finding undervalued opportunities in the Swedish stock market requires more than just screening low price-to-earnings ratios. As we move into 2026, several Swedish-listed companies on the Nasdaq Stockholm continue to trade below their intrinsic value due to macroeconomic pressure, cyclical downturns, and temporary sector-specific headwinds. Despite Sweden’s reputation for strong corporate governance and globally competitive industrial firms, the market still offers hidden value opportunities for long-term investors who focus on fundamentals rather than short-term volatility. Below is a structured analysis of some of the most compelling undervalued Swedish stocks in 2026, categorized by their core value drivers. 1. Industrial Giants Trading Below Fair Value Sweden is home to globally recognized industrial le...
Post a Comment
Read more